1. The enhanced antitumour response of pimozide combined with the IDO inhibitor L‑MT in melanoma
   Huijie Jia et al, 2018, International Journal of Oncology CrossRef
2. Hepatobiliary Tumors: Immunopathology and Immunotherapy
   Nazanin Momeni Roudsari et al, 2020, Cancer Immunology CrossRef
3. Anti-aging effect of nifuroxazide on skin changes of aged male rat models via modulating immunoreactivity of IL-6/NF-κB/Caspase-3
   R.M. Salama et al, 2023, Morphologie CrossRef
4. Molecular Targets in Hepatocarcinogenesis and Implications for Therapy
   Meng-Yu Wu et al, 2018, Journal of Clinical Medicine CrossRef
5. Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
   Yu Jiang et al, 2019, World Journal of Gastroenterology CrossRef
6. Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study
   Cailing Gan et al, 2022, Respiratory Research CrossRef
7. Pharmacological updates of nifuroxazide: Promising preclinical effects and the underlying molecular mechanisms
   Hanan S. Althagafy et al, 2023, European Journal of Pharmacology CrossRef
8. Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges
   Xiaopei Hao et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
9. Directional Hemispherical Reflectance in the Analysis of Expired and Unexpired Tablets Containing Nifuroxazide—The Results of a Pilot Study
   Beata Sarecka-Hujar et al, 2022, ECP 2022 CrossRef
10. Combination of attenuated Salmonella carrying PD‐1 siRNA with nifuroxazide for colon cancer therapy
    Tiesuo Zhao et al, 2020, Journal of Cellular Biochemistry CrossRef
11. Drug repurposing: An emerging strategy in alleviating skin cancer
    Popat Kumbhar et al, 2022, European Journal of Pharmacology CrossRef
12. Synthesis of New Nifuroxazide Derivatives Based on Nitropyrrole Skeleton with Good Antitumor Activity in Vitro
    Huaxin Luo et al, 2024, ChemistrySelect CrossRef
13. IDO2-siRNA Carried by Salmonella Combined with Nifuroxazide Attenuates Melanoma Growth
    Tiesuo Zhao et al, 2023, Current Molecular Pharmacology CrossRef
14. Nifuroxazide Mitigates Angiogenesis in Ehlrich’s Solid Carcinoma: Molecular Docking, Bioinformatic and Experimental Studies on Inhibition of Il-6/Jak2/Stat3 Signaling
    Mohamed El-Sherbiny et al, 2021, Molecules CrossRef
15. Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling
    Sameh Saber et al, 2023, Biomedicine & Pharmacotherapy CrossRef
16. Vaccination with FasL-/TCL plus MHSP65 induces improved anti-lung cancer immunity in mice
    Bohan Dong et al, 2018, International Immunopharmacology CrossRef
17. Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations
    Yingjun Xie et al, 2018, Journal of Immunology Research CrossRef
18. Nifuroxazide boosts the anticancer efficacy of palbociclib-induced senescence by dual inhibition of STAT3 and CDK2 in triple-negative breast cancer
    Xianzhe Wang et al, 2023, Cell Death Discovery CrossRef
19. Toward a repositioning of the antibacterial drug nifuroxazide for cancer treatment
    Christian Bailly, 2019, Drug Discovery Today CrossRef